Weight-Loss drug shows promise for gout relief in obese patients
NCT ID NCT07326839
First seen Jan 09, 2026 · Last updated May 07, 2026 · Updated 17 times
Summary
This study tests whether orlistat, a weight-loss medication, combined with a structured diet and exercise program, can help obese people with gout lower their uric acid levels and reduce gout attacks. 120 participants will receive either orlistat or a placebo for 24 weeks. The goal is to see if this approach improves gout control beyond standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
General Hospital of Northern Theater Command, PLA
Shenyang, Liaoning, 110016, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.